SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ -- BlackfinBio Ltd (BFB) a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases has announced today that it has acquired the Parkinson's patent portfolio from OXB. BlackfinBio Ltd...
Hence then, the article about blackfinbio ltd announces the acquisition of parkinson s ip patent portfolio from oxb was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BlackfinBio Ltd announces the acquisition of Parkinson's IP patent portfolio from OXB )
Also on site :
- 5 High-Flying Energy Stocks Trouncing The Markets
- Guidehouse Unveils Financial Management AI Solution Powered by Databricks
- Meta Reports Fourth Quarter and Full Year 2025 Results